CAMECO CORP (CCJ)

CA13321L1085 - Common Stock

48.68  -0.56 (-1.14%)

Fundamental Rating

4

CCJ gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 209 industry peers in the Oil, Gas & Consumable Fuels industry. CCJ scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. CCJ is valied quite expensively at the moment, while it does show a decent growth rate.



3

1. Profitability

1.1 Basic Checks

CCJ had positive earnings in the past year.
CCJ had a positive operating cash flow in the past year.
The reported net income has been mixed in the past 5 years: CCJ reported negative net income in multiple years.
In the past 5 years CCJ always reported a positive cash flow from operatings.

1.2 Ratios

The Return On Assets of CCJ (1.25%) is worse than 72.06% of its industry peers.
The Return On Equity of CCJ (1.88%) is worse than 72.06% of its industry peers.
With a Return On Invested Capital value of 2.95%, CCJ is not doing good in the industry: 73.04% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 1.25%
ROE 1.88%
ROIC 2.95%
ROA(3y)1.1%
ROA(5y)0.72%
ROE(3y)1.78%
ROE(5y)1.15%
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

With a Profit Margin value of 4.17%, CCJ is not doing good in the industry: 66.18% of the companies in the same industry are doing better.
CCJ's Profit Margin has improved in the last couple of years.
CCJ has a Operating Margin of 12.49%. This is in the lower half of the industry: CCJ underperforms 62.25% of its industry peers.
CCJ's Operating Margin has improved in the last couple of years.
CCJ has a worse Gross Margin (23.81%) than 66.18% of its industry peers.
In the last couple of years the Gross Margin of CCJ has grown nicely.
Industry RankSector Rank
OM 12.49%
PM (TTM) 4.17%
GM 23.81%
OM growth 3YN/A
OM growth 5Y26.02%
PM growth 3YN/A
PM growth 5Y11.89%
GM growth 3Y54.28%
GM growth 5Y8.95%

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), CCJ is destroying value.
CCJ has more shares outstanding than it did 1 year ago.
CCJ has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, CCJ has a worse debt to assets ratio.

2.2 Solvency

An Altman-Z score of 7.03 indicates that CCJ is not in any danger for bankruptcy at the moment.
CCJ has a better Altman-Z score (7.03) than 91.67% of its industry peers.
CCJ has a debt to FCF ratio of 3.27. This is a good value and a sign of high solvency as CCJ would need 3.27 years to pay back of all of its debts.
With a decent Debt to FCF ratio value of 3.27, CCJ is doing good in the industry, outperforming 69.12% of the companies in the same industry.
CCJ has a Debt/Equity ratio of 0.20. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of CCJ (0.20) is better than 67.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 3.27
Altman-Z 7.03
ROIC/WACC0.39
WACC7.67%

2.3 Liquidity

A Current Ratio of 2.88 indicates that CCJ has no problem at all paying its short term obligations.
With an excellent Current ratio value of 2.88, CCJ belongs to the best of the industry, outperforming 80.88% of the companies in the same industry.
CCJ has a Quick Ratio of 1.26. This is a normal value and indicates that CCJ is financially healthy and should not expect problems in meeting its short term obligations.
CCJ's Quick ratio of 1.26 is fine compared to the rest of the industry. CCJ outperforms 63.73% of its industry peers.
Industry RankSector Rank
Current Ratio 2.88
Quick Ratio 1.26

6

3. Growth

3.1 Past

The earnings per share for CCJ have decreased strongly by -29.85% in the last year.
Measured over the past 5 years, CCJ shows a small growth in Earnings Per Share. The EPS has been growing by 7.91% on average per year.
The Revenue has grown by 23.31% in the past year. This is a very strong growth!
The Revenue has been growing slightly by 4.35% on average over the past years.
EPS 1Y (TTM)-29.85%
EPS 3YN/A
EPS 5Y7.91%
EPS Q2Q%-103.12%
Revenue 1Y (TTM)23.31%
Revenue growth 3Y12.86%
Revenue growth 5Y4.35%
Sales Q2Q%25.32%

3.2 Future

Based on estimates for the next years, CCJ will show a very strong growth in Earnings Per Share. The EPS will grow by 32.22% on average per year.
Based on estimates for the next years, CCJ will show a quite strong growth in Revenue. The Revenue will grow by 8.75% on average per year.
EPS Next Y-25.04%
EPS Next 2Y42.5%
EPS Next 3Y38.67%
EPS Next 5Y32.22%
Revenue Next Year18.89%
Revenue Next 2Y13.93%
Revenue Next 3Y10.95%
Revenue Next 5Y8.75%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.

1

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 147.52 indicates a quite expensive valuation of CCJ.
Based on the Price/Earnings ratio, CCJ is valued a bit more expensive than 76.47% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 26.91, CCJ is valued quite expensively.
A Price/Forward Earnings ratio of 43.72 indicates a quite expensive valuation of CCJ.
Based on the Price/Forward Earnings ratio, CCJ is valued a bit more expensive than 72.06% of the companies in the same industry.
When comparing the Price/Forward Earnings ratio of CCJ to the average of the S&P500 Index (23.26), we can say CCJ is valued expensively.
Industry RankSector Rank
PE 147.52
Fwd PE 43.72

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, CCJ is valued more expensive than 80.39% of the companies in the same industry.
62.25% of the companies in the same industry are cheaper than CCJ, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 79.08
EV/EBITDA 55.89

4.3 Compensation for Growth

CCJ's earnings are expected to grow with 38.67% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)18.66
EPS Next 2Y42.5%
EPS Next 3Y38.67%

3

5. Dividend

5.1 Amount

CCJ has a yearly dividend return of 0.22%, which is pretty low.
CCJ's Dividend Yield is slightly below the industry average, which is at 6.60.
Compared to an average S&P500 Dividend Yield of 2.34, CCJ's dividend is way lower than the S&P500 average.
Industry RankSector Rank
Dividend Yield 0.22%

5.2 History

The dividend of CCJ decreases each year by -7.75%.
CCJ has paid a dividend for at least 10 years, which is a reliable track record.
CCJ has not decreased its dividend in the past 5 years, so it has a somewhat stable track record.
Dividend Growth(5Y)-7.75%
Div Incr Years1
Div Non Decr Years6

5.3 Sustainability

CCJ pays out 44.71% of its income as dividend. This is a bit on the high side, but may be sustainable.
DP44.71%
EPS Next 2Y42.5%
EPS Next 3Y38.67%

CAMECO CORP

NYSE:CCJ (1/13/2025, 3:21:10 PM)

48.68

-0.56 (-1.14%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)11-07 2024-11-07/bmo
Earnings (Next)02-07 2025-02-07/amc
Inst Owners76.29%
Inst Owner Change-0.07%
Ins Owners0.42%
Ins Owner ChangeN/A
Market Cap21.19B
Analysts82.67
Price Target83.03 (70.56%)
Short Float %3.87%
Short Ratio4.1
Dividend
Industry RankSector Rank
Dividend Yield 0.22%
Dividend Growth(5Y)-7.75%
DP44.71%
Div Incr Years1
Div Non Decr Years6
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-75.2%
Min EPS beat(2)-103.96%
Max EPS beat(2)-46.43%
EPS beat(4)0
Avg EPS beat(4)-52.63%
Min EPS beat(4)-103.96%
Max EPS beat(4)-5.49%
EPS beat(8)3
Avg EPS beat(8)-10.58%
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-13.28%
Min Revenue beat(2)-22.8%
Max Revenue beat(2)-3.76%
Revenue beat(4)1
Avg Revenue beat(4)-11.5%
Min Revenue beat(4)-22.8%
Max Revenue beat(4)2.54%
Revenue beat(8)3
Avg Revenue beat(8)-6.5%
Revenue beat(12)5
Avg Revenue beat(12)-3.36%
Revenue beat(16)6
Avg Revenue beat(16)-2.42%
PT rev (1m)0%
PT rev (3m)10.34%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-21.04%
EPS NY rev (1m)-6.59%
EPS NY rev (3m)-33.75%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)19.32%
Revenue NY rev (1m)0.03%
Revenue NY rev (3m)-1.07%
Valuation
Industry RankSector Rank
PE 147.52
Fwd PE 43.72
P/S 10.92
P/FCF 79.08
P/OCF 52.92
P/B 4.92
P/tB 4.95
EV/EBITDA 55.89
EPS(TTM)0.33
EY0.68%
EPS(NY)1.11
Fwd EY2.29%
FCF(TTM)0.62
FCFY1.26%
OCF(TTM)0.92
OCFY1.89%
SpS4.46
BVpS9.9
TBVpS9.84
PEG (NY)N/A
PEG (5Y)18.66
Profitability
Industry RankSector Rank
ROA 1.25%
ROE 1.88%
ROCE 3.99%
ROIC 2.95%
ROICexc 3.02%
ROICexgc 3.04%
OM 12.49%
PM (TTM) 4.17%
GM 23.81%
FCFM 13.8%
ROA(3y)1.1%
ROA(5y)0.72%
ROE(3y)1.78%
ROE(5y)1.15%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5Y23.63%
ROICexc growth 3YN/A
ROICexc growth 5Y23.76%
OM growth 3YN/A
OM growth 5Y26.02%
PM growth 3YN/A
PM growth 5Y11.89%
GM growth 3Y54.28%
GM growth 5Y8.95%
F-Score5
Asset Turnover0.3
Health
Industry RankSector Rank
Debt/Equity 0.2
Debt/FCF 3.27
Debt/EBITDA 2.21
Cap/Depr 85.85%
Cap/Sales 6.82%
Interest Coverage 4.25
Cash Conversion 100.93%
Profit Quality 331.39%
Current Ratio 2.88
Quick Ratio 1.26
Altman-Z 7.03
F-Score5
WACC7.67%
ROIC/WACC0.39
Cap/Depr(3y)67.49%
Cap/Depr(5y)53.38%
Cap/Sales(3y)6.77%
Cap/Sales(5y)5.73%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-29.85%
EPS 3YN/A
EPS 5Y7.91%
EPS Q2Q%-103.12%
EPS Next Y-25.04%
EPS Next 2Y42.5%
EPS Next 3Y38.67%
EPS Next 5Y32.22%
Revenue 1Y (TTM)23.31%
Revenue growth 3Y12.86%
Revenue growth 5Y4.35%
Sales Q2Q%25.32%
Revenue Next Year18.89%
Revenue Next 2Y13.93%
Revenue Next 3Y10.95%
Revenue Next 5Y8.75%
EBIT growth 1Y67.54%
EBIT growth 3YN/A
EBIT growth 5Y31.5%
EBIT Next Year298.84%
EBIT Next 3Y80.66%
EBIT Next 5Y49.81%
FCF growth 1Y177.09%
FCF growth 3YN/A
FCF growth 5Y-2.67%
OCF growth 1Y101.64%
OCF growth 3Y129.54%
OCF growth 5Y0.61%